4Bio Annual General Meeting, The Royal Institution, London, October 2025: Laurie spoke at the annual general meeting of 4Bio, a private equity fund focused on cell and gene therapy companies. The Royal Institution was founded in 1795 to honor scientific advances.

10th Annual CAR-TCR Summit, Boston Public Library, September 2025: Laurie spoke at one of the leading annual gatherings for cell and gene therapy researchers and clinicians.

Kite Pharma 25,000th CAR-T Patient Celebration, Santa Monica, December 2024: Company-wide celebration of a milestone. Laurie spoke on a moderated panel alongside another long-term CAR-T patient, Branden, who received the treatment for pediatric leukemia the same year as Laurie.

Kite Pharma Oceanside, June 2023: Fourth Kite facility visit. Laurie toured the viral vector manufacturing facility, spoke to employees for an hour, fielded their questions, and had dinner with management. Kite's Oceanside facility is where they manufacture the viral vector used to engineer patients' T cells into CAR-T cells.

Lykan Bioscience, September 2021: Laurie toured the cell manufacturing facility and spoke to employees about her CAR-T experience. Lykan is a turnkey cell manufacturing company working on innovative programs for cancer, autoimmune and neurological diseases.

Kite Pharma National Sales Meeting, February 2021: Approximately 300 attendees, held over Zoom. Laurie spoke for approximately one hour about her CAR-T experience in advance of the FDA approval of Yescarta for follicular NHL. One of her first major industry appearances.

Sinai Temple, Los Angeles, December 2019: Invited by Rabbi David Wolpe to speak at Shabbat Services about her cancer journey. Several hundred people in attendance. At the conclusion of the service, congregants came to speak to her about their own journeys with cancer.